Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates
In a first-of-its-kind RCT, early testosterone access led to an 11.6-point improvement in self-rated health scores among transgender and gender-diverse adults, while delayed-treatment controls showed no significant change.
Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.
Researchers found "no increased risk of invasive cervical cancer or high-grade cervical intraepithelial neoplasia in transmasculine and gender-diverse (TMGD) [individuals] using gender-affirming hormone therapy," but added that the findings should be interpreted with caution.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.